轨道动脉切除术的优点:一个案例系列
Atit A Gawalkar1, Krishna Prasad Akkineni1, Rajesh Vijayvergiya2
1All India Institute of Medical Sciences, New Delhi, India.
概括
轨道切除术 (OA) 为修改严重化的冠状动脉病变提供了独特的优势,特别是在复杂的情况下. 这种方法为除提供了一个有价值的选择,当其他技术可能不太适合时,减少并发症风险.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管成像 - 心血管成像
- 医疗器械技术 医疗器械技术
背景情况:
- 严重的冠状动脉化在穿皮冠状动脉干预 (PCI) 期间带来了重大挑战.
- 旋转性切除术是切除的常见方法,因为它的有效性和成本.
- 某些状病变可以从轨道切除术 (OA) 等替代方法中获益.
研究的目的:
- 要突出轨道切除术 (OA) 在修改复杂的结石化冠状动脉病变方面的特定优势.
- 提出案例研究,证明OA比其他技术的首选使用.
- 展示支持OA在修饰中的疗效的成像证据.
主要方法:
- 对三名冠状动脉严重化的患者进行了基于案例的审查.
- 轨道切除术与其他修饰技术的比较分析.
- 包括血管内成像来评估病变的改变.
主要成果:
- 轨道切除术成功地用于复杂的状损伤,而其他方法不太适合.
- 图像检测证实了OA后化病变的有效修改.
- 在特定的场景中,OA 证明了其实用性,例如尺寸不匹配,偏心和靠近支架的位置.
结论:
- 轨道切除术是特定的复杂冠状动脉化子集中除的宝贵工具.
- 在具有挑战性的解剖学情况下,OA提供了更安全的替代方案,降低了并发症风险.
- 一个多方位的方法是必要的,以实现最佳的管理的结石冠状动脉病变.
相关概念视频
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655


